Raul Santos: It’s Time Science Wins the War Against Bad Opinions and Lies on Statins
Raul Santos, Researcher at ARO, Hospital Israelita Albert Einstein, shared on LinkedIn about a recent article he co-authored with Timo Strandberg, adding:
”In this editorial, written by Timo Strandberg and me in the The Lancet, we comment on the most recent CTT meta-analysis on statin safety. Statins have changed how we practice preventive medicine: these drugs prevent myocardial infarction and stroke, reduce ischemia and the need for revascularization, and prolong life! Statins, as well as cholesterol reduction, are safe; this was clearly shown by the Oxford group’s robust patient-level meta-analysis.
Indeed, statins may raise glucose levels, and patients with prediabetes may pass the diagnosis threshold and develop diabetes; also, elevations in AST/ALT without clinical significance may occur. Finally, statins may cause tubular proteinuria (reduction in absorption) and mild edema; however, these are rare and of no clinical significance. It’s about time science wins the war against bad opinions and lies!՛՛
Title: Product labels downplay the safety of statin therapy: evidence from randomised controlled trials
Authors: Timo E Strandberga, Raul D Santos
Read the Full Article on The Lancet.
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 9, 2026, 14:45Heghine Khachatryan: We Already Have The Knowledge Not to Overlook Rare Diseases
-
Feb 9, 2026, 14:42Ed Shovelin: PDE Inhibitors Preferentially Affect ADP and TRAP6 Activation
-
Feb 9, 2026, 14:40Jecko Thachil: Steroids May Be Associated With Arterial and Venous Thrombosis
-
Feb 9, 2026, 14:36Mohammad Reza Fattahi: Breast Arterial Calcifications as a Marker of Stroke Risk in Women
-
Feb 9, 2026, 14:28Shubham Misra: Biomarker Discovery for LVO, AFib Detection, and Post-Stroke Epilepsy at ISC 2026
-
Feb 9, 2026, 14:27Wolfgang Miesbach: Discussing Model-Informed Precision Dosing of Fitusiran at EAHAD 2026
-
Feb 9, 2026, 14:22Valance Washington: An Evidence-Based View on Emerging Therapies for Thrombotic Disorders
-
Feb 9, 2026, 14:19Nathan Connell: Advancing Prophylaxis for von Willebrand Disease with HMB-002
-
Feb 9, 2026, 14:11Chayanin Tangwiriyasakul: Using NeuroAI to Estimate Stroke Perfusion Deficits